Assessing metastasis risk after pre-operative anti-angiogenic therapy

Anti-angiogenic drugs are approved for the treatment of several cancer types, generally in the inoperable locally advanced or metastatic setting and in combination with other anti-cancer agents. Recent clinical studies also suggest that anti-angiogenic drugs can be useful in the pre-operative (neoad...

Descripción completa

Detalles Bibliográficos
Autores principales: Biziato, Daniela, De Palma, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Closeups
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287970/
https://www.ncbi.nlm.nih.gov/pubmed/25394647
http://dx.doi.org/10.15252/emmm.201404640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287970/
https://www.ncbi.nlm.nih.gov/pubmed/25394647
http://dx.doi.org/10.15252/emmm.201404640

Ejemplares similares